Cargando…

Differentiating Familial Chylomicronemia Syndrome From Multifactorial Severe Hypertriglyceridemia by Clinical Profiles

CONTEXT: Differentiation between familial chylomicronemia syndrome (FCS, type 1 hyperlipoproteinemia), a rare metabolic disorder, and the more common multifactorial severe hypertriglyceridemia (sHTG, type 5 hyperlipoproteinemia) is challenging because of their overlapping symptoms but important in p...

Descripción completa

Detalles Bibliográficos
Autores principales:	O’Dea, Louis St L, MacDougall, James, Alexander, Veronica J, Digenio, Andres, Hubbard, Brant, Arca, Marcello, Moriarty, Patrick M, Kastelein, John J P, Bruckert, Eric, Soran, Handrean, Witztum, Joseph L, Hegele, Robert A, Gaudet, Daniel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Endocrine Society 2019
Materias:	Clinical Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6864364/ https://www.ncbi.nlm.nih.gov/pubmed/31777768 http://dx.doi.org/10.1210/js.2019-00214

Ejemplares similares

Dissection of Clinical and Gene Expression Signatures of Familial versus Multifactorial Chylomicronemia
por: Tremblay, Karine, et al.
Publicado: (2020)

The Evolving Story of Multifactorial Chylomicronemia Syndrome
por: Paquette, Martine, et al.
Publicado: (2022)

Recurrent Hypertriglyceridemia-Induced Pancreatitis due to Multifactorial Chylomicronemia Syndrome in a Patient With Ketosis-Prone Diabetes Mellitus
por: Yotsapon, Thewjitcharoen, et al.
Publicado: (2022)

ODP153 Recurrent hypertriglyceridemia-induced pancreatitis due to multifactorial chylomicronemia syndrome in a patient with ketosis-prone diabetes mellitus
por: Thewjitcharoen, Yotsapon, et al.
Publicado: (2022)

Hypertriglyceridemia Induced Pancreatitis (Chylomicronemia Syndrome) Treated with Supportive Care
por: Uysal, Emin, et al.
Publicado: (2014)

Causes, clinical findings and therapeutic options in chylomicronemia syndrome, a special form of hypertriglyceridemia
por: Paragh, György, et al.
Publicado: (2022)

Management of Patients with Type V Hyperlipoproteinemia: An Uncommon Phenotype of Dyslipidemia with Chylomicronemia and Severe Hypertriglyceridemia
por: Chang, Ya-Hui, et al.
Publicado: (2022)

Non-Alcoholic Fatty Liver in Patients with Chylomicronemia
por: Maltais, Mélanie, et al.
Publicado: (2021)

The burden of familial chylomicronemia syndrome in Canadian patients
por: Gaudet, Daniel, et al.
Publicado: (2020)

Hypertriglyceridemia
por: Brahm, Amanda, et al.
Publicado: (2013)

Rare Treatments for Rare Dyslipidemias: New Perspectives in the Treatment of Homozygous Familial Hypercholesterolemia (HoFH) and Familial Chylomicronemia Syndrome (FCS)
por: D’Erasmo, Laura, et al.
Publicado: (2021)

Characterisation of patients with familial chylomicronaemia syndrome (FCS) and multifactorial chylomicronaemia syndrome (MCS): Establishment of an FCS clinical diagnostic score
por: Moulin, Philippe, et al.
Publicado: (2018)

Genetics of Hypertriglyceridemia
por: Dron, Jacqueline S., et al.
Publicado: (2020)

Deficient Cholesterol Esterification in Plasma of apoc2 Knockout Zebrafish and Familial Chylomicronemia Patients
por: Liu, Chao, et al.
Publicado: (2017)

FRI093 Severe Hypertriglyceridemia Post Liver Transplant- A Multifactorial Disorder
por: Saand, Aisha R, et al.
Publicado: (2023)

Post-prandial analysis of fluctuations in the platelet count and platelet function in patients with the familial chylomicronemia syndrome
por: Larouche, Miriam, et al.
Publicado: (2023)

A Comprehensive Update on the Chylomicronemia Syndrome
por: Goldberg, Ronald B., et al.
Publicado: (2020)

Current Diagnosis and Management of Primary Chylomicronemia
por: Okazaki, Hiroaki, et al.
Publicado: (2021)

Effect of the DGAT1 inhibitor pradigastat on triglyceride and apoB48 levels in patients with familial chylomicronemia syndrome
por: Meyers, Charles Daniel, et al.
Publicado: (2015)

Deletion of GPIHBP1 causing severe chylomicronemia
por: Rios, Jonathan J., et al.
Publicado: (2011)

Two Case Reports of Familial Chylomicronemia Syndrome
por: Chen, Yan-Hui, et al.
Publicado: (2012)

Familial chylomicronemia syndrome: a case report
por: Susheela, Ammu Thampi, et al.
Publicado: (2021)

Familial chylomicronemia syndrome: importance of diagnostic vigilance
por: Ueda, Masako
Publicado: (2022)

Genetic determinants of pancreatitis: relevance in severe hypertriglyceridemia
por: Hang, Shyann M.T., et al.
Publicado: (2023)

OR21-3 Familial Chylomicronemia Syndrome: Distinguishing the Rare Among the Common in Adults for Appropriate Management
por: Ueda, Masako, et al.
Publicado: (2019)

Homozygous missense mutation (G56R) in glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 (GPI-HBP1) in two siblings with fasting chylomicronemia (MIM 144650)
por: Wang, Jian, et al.
Publicado: (2007)

Pregnancy in Familial Chylomicronemia Syndrome: Plasmapheresis as Therapeutic Approach
por: Leskovar, Dunja, et al.
Publicado: (2021)

Familial chylomicronemia syndrome in children: a diagnosis challenge
por: Ariza, María José, et al.
Publicado: (2022)

SUN-593 Variants in Known Monogenic Causal Genes of Hypertriglyceridemia Are Not Major Contributors for Hypertriglyceridemia in Lipodystrophy Due to a LMNA Mutation
por: Ueda, Masako, et al.
Publicado: (2020)

FRI092 Rationale And Design Of The Balance Study: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study Of Olezarsen In Patients With Familial Chylomicronemia Syndrome
por: Alexander, Veronica, et al.
Publicado: (2023)

Lipoprotein Lipase Deficiency in an Infant With Chylomicronemia, Hepatomegaly, and Lipemia Retinalis
por: Vidanapathirana, Dinesha Maduri, et al.
Publicado: (2017)

Chylomicronemia through a burr hole: A case report
por: Loh, Wann Jia, et al.
Publicado: (2022)

Vupanorsen, an N-acetyl galactosamine-conjugated antisense drug to ANGPTL3 mRNA, lowers triglycerides and atherogenic lipoproteins in patients with diabetes, hepatic steatosis, and hypertriglyceridaemia
por: Gaudet, Daniel, et al.
Publicado: (2020)

Apolipoprotein C-III reduction in subjects with moderate hypertriglyceridaemia and at high cardiovascular risk
por: Tardif, Jean-Claude, et al.
Publicado: (2022)

An interesting case of familial chylomicronemia syndrome in a cleft palate child
por: Adenwalla, H. S., et al.
Publicado: (2008)

Clinical, biochemical and molecular analysis of two infants with familial chylomicronemia syndrome
por: Zhang, Yonghong, et al.
Publicado: (2016)

Development of a novel PRO instrument for use in familial chylomicronemia syndrome
por: Davidson, David, et al.
Publicado: (2021)

Familial Chylomicronemia Syndrome-Induced Acute Necrotizing Pancreatitis during Pregnancy
por: Coronado Arroyo, Julia Cristina, et al.
Publicado: (2021)

Heterozygous CAV1 frameshift mutations (MIM 601047) in patients with atypical partial lipodystrophy and hypertriglyceridemia
por: Cao, Henian, et al.
Publicado: (2008)

Evidence-based goals in LDL-C reduction
por: Soran, Handrean, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_sh14t2n13mejo930v8cqvfjush